跳至主要内容
临床试验/PACTR201908521430230
PACTR201908521430230尚未招募未知

Progress of labour with hyoscine-n-butyl bromide: a randomized double-blind placebo-controlled study

Fagbohun0 个研究点目标入组 172 人开始时间: 2019年7月26日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Multiparous pregnant women aged 18-40 years, with singleton pregnancy in cephalic presentation, admitted in active phase (at cervical dilatation of 4 to 6 cm) of spontaneous labour at term (37 weeks – 41 weeks + 6 days gestation) whose rate of cervical dilatation is less than 1 cm per hour as assessed four hours into admission

排除标准

  • Grand multiparity
  • Multiple pregnancy
  • Previous uterine scar
  • Cervical dilation = 7 cm at admission
  • Cervical cerclage
  • Chronic or pregnancy induced medical conditions
  • Presence of any contraindication to vaginal delivery
  • Allergy to hyoscine-n-butyl bromide
  • History suggestive of, or previous diagnoses of glaucoma, myasthenia gravis, obstructive uropathy, asthma, cardiac, liver or renal disease, seizure disorder or psychiatric illness
  • Prolonged Prelabour rupture of the fetal membranes (rupture of fetal membrane with latency period greater than 24hrs)
  • Congenital fetal malformations
  • Intra uterine growth restriction (IUGR)
  • Cephalopelvic disproportion
  • Intrauterine fetal death (IUFD)
  • Non consenting patient

研究者

发起方
Fagbohun

相似试验